Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulnar Hafiz

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
American Journal of Ophthalmology|March 2, 2010
Topical mecamylamine for diabetic macular edemaPeter A Campochiaro, Syed Mahmood Shah, Gulnar Hafiz, et al.
American Journal of Ophthalmology|October 21, 2015
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosaXiangrong Kong, Folahan Ibukun, Muhammad J Khan, et al.
American Journal of Ophthalmology|April 8, 2019
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular EdemaMustafa Iftikhar, Tahreem A Mir, Gulnar Hafiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
American Journal of Ophthalmology|April 25, 2015
Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) StudyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
American Journal of Ophthalmology|August 27, 2016
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Ophthalmology|May 1, 2016
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
American Journal of Ophthalmology|March 2, 2010
Topical mecamylamine for diabetic macular edemaPeter A Campochiaro, Syed Mahmood Shah, Gulnar Hafiz, et al.
American Journal of Ophthalmology|October 21, 2015
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosaXiangrong Kong, Folahan Ibukun, Muhammad J Khan, et al.
American Journal of Ophthalmology|April 8, 2019
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular EdemaMustafa Iftikhar, Tahreem A Mir, Gulnar Hafiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
American Journal of Ophthalmology|April 25, 2015
Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) StudyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
American Journal of Ophthalmology|August 27, 2016
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
American Journal of Ophthalmology|May 1, 2016
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Pageof 3